May 14, 2021 / 12:30PM GMT
Operator
Good morning, ladies and gentlemen, and welcome to the Protalix BioTherapeutics First Quarter 2021 Financial and Business Results Conference Call. As a reminder, this conference call is being recorded.
I will now turn the conference over to our host, Mr. Chuck Padala of LifeSci Advisors Investor Relations. Chuck, you may now begin the presentation.
Charles Padala -
Thank you, Rob. Welcome, everyone, to the Protalix BioTherapeutics first quarter 2021 financial results and business update conference call. With me today are Mr. Dror Bashan, President and CEO of Protalix; and Mr. Eyal Rubin, Chief Financial Officer.
The press release announcing the results and the update was issued this morning and is now available on the Protalix website. Please take a moment to read the disclaimer about the forward-looking statements in the press release. The earnings release and the teleconference include forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ
Q1 2021 Protalix Biotherapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot